Trademark Overview
On Monday, September 9, 2024, a trademark application was filed for BESREMI PEN with the United States Patent and Trademark Office. The USPTO has given the BESREMI PEN trademark a serial number of 98739864. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, September 9, 2024. This trademark is owned by PHARMAESSENTIA CORPORATION. The BESREMI PEN trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations, namely, ropeginterferon alfa-2b, contained in pen injectors for treatment of viral infections, cancers, polycythemia vera, essential thrombocythemia, myelofibrosis, and/or other myeloproliferative neoplasms; Pharmaceutical preparations contained in pen injectors; Pharmaceutical preparations contained in pen injectors for treatment of myeloproliferative neoplasms; Pharmaceutical preparations contained in injectors for treatment of myeloproliferative neoplasms; Pharmaceutical preparations contained in injectors; Pharmaceutical preparations, namely, ropeginterferon alfa-2b, contained in injectors for treatment of viral infections, cancers, polycythemia vera, essential thrombocythemia, myelofibrosis, and/or other myeloproliferative neoplasms
